Skip to main content

Table 1 Participants’ characteristics

From: Whether, when, how, and how much? General public’s and cancer patients’ views about the disclosure of genomic secondary findings

 

Group 1

Group 2

Group 3

Group 4

Group 5

Group 6

Group 7

Group 8

Total

N = 61

Participants

 Public

10

7

7

8

    

32

 Patients

    

9

7

8

5

29

Location

 Québec City

10

7

  

9

7

  

33

 Montréal

  

7

8

  

8

5

28

Gender

 Female

10

 

7

 

9

 

8

 

34

 Male

 

7

 

8

 

7

 

5

27

Age groups

 25 or less

0

2

2

1

0

0

0

0

5

 26 to 35

4

0

2

2

0

0

0

0

8

 36 to 50

1

3

1

3

5

0

4

0

17

 50 or more

5

2

2

2

4

7

4

5

31

Education

 High school

7

4

4

5

3

3

3

1

30

 College

3

3

3

3

6

4

5

4

31